NCT05803395 2023-11-28
Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.
Gruppo Italiano Malattie EMatologiche dell'Adulto
Unknown
Gruppo Italiano Malattie EMatologiche dell'Adulto
Huashan Hospital
Ospedale di Circolo - Fondazione Macchi
Centro Universitário de Anapolis
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
Bicetre Hospital